Cite

HARVARD Citation

    Modest, D. et al. (2018). Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3. European journal of cancer. pp. 77-86. [Online]. 
  
Back to record